Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Computed Tomography (CT) in Head and Neck Patients

This study has been terminated.
(insufficient recruitment)
Information provided by:
University Health Network, Toronto Identifier:
First received: September 12, 2005
Last updated: December 14, 2010
Last verified: December 2010
This study is conducting a comparison of chest x-ray (CXR) and minimum dose thoracic CT (MnDCT) in the detection of lung nodules (metastases) in patients with head and neck carcinoma.

Condition Intervention Phase
Lung Tumors
Procedure: CT thorax
Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Minimum Dose CT in the Detection of Lung Nodules in Patients With Head and Neck Cancer

Resource links provided by NLM:

Further study details as provided by University Health Network, Toronto:

Primary Outcome Measures:
  • Detection of lung metastases

Estimated Enrollment: 100
Study Start Date: August 2003
Estimated Study Completion Date: September 2006
Detailed Description:
A comparison of chest x-ray (CXR) and minimum dose thoracic CT (MnDCT)in the detection of lung nodules (metastases) in patients with head and neck carcinoma

Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with squamous cell carcinoma of the head and neck

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00188656

Canada, Ontario
Princess Margaret Hospital
Toronto, Ontario, Canada
Sponsors and Collaborators
University Health Network, Toronto
Principal Investigator: Narinder Paul, FRCP C University Health Network, Toronto
  More Information Identifier: NCT00188656     History of Changes
Other Study ID Numbers: 03-0467
Study First Received: September 12, 2005
Last Updated: December 14, 2010 processed this record on April 28, 2017